Related Experiment Video

Updated: Aug 8, 2026

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation
07:20

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 15, 2011

I-kappa B kinase beta is critical for B cell proliferation and antibody response

Hong Ren1, Aurelia Schmalstieg, Dorothy Yuan

  • 1Division of Hematology-Oncology, Department of Medicine, Harold Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

Journal of Immunology (Baltimore, Md. : 1950)
|January 5, 2002
PubMed

Insights

I-kappaB kinase beta (IKKbeta) is crucial for B cell proliferation and humoral immune responses. Transgenic mice lacking functional IKKbeta in B cells showed impaired cell cycle progression and antibody production.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Biology

Background:

  • Nuclear factor-kappaB (NF-kappaB) proteins regulate immune and inflammatory responses.
  • NF-kappaB pathway activation involves I-kappaB kinase beta (IKKbeta) phosphorylation and I-kappaB degradation, leading to NF-kappaB nuclear translocation.

Purpose of the Study:

  • To investigate the role of IKKbeta in B cell function using transgenic mice.
  • To determine the impact of IKKbeta deficiency on B lymphocyte development, activation, and antibody production.

Main Methods:

  • Generation of transgenic mice expressing a dominant-negative IKKbeta mutant under the IgH promoter.
  • Assessment of B cell development, basal immunoglobulin (Ig) levels, and NF-kappaB pathway activation.
  • Analysis of B cell proliferation in response to lipopolysaccharide (LPS), anti-CD40, and anti-IgM stimulation.
  • Evaluation of Ig subclass production against T-dependent and T-independent antigens.

Main Results:

  • Transgenic mice exhibited defective NF-kappaB pathway activation in B cells.
  • No significant defects were observed in B lymphocyte development or basal Ig levels.
  • Impaired B cell cycle progression and proliferation were noted upon stimulation with LPS, anti-CD40, and anti-IgM.
  • Selective defects in the production of specific Ig subclasses were observed in response to various antigens.

Conclusions:

  • IKKbeta plays a critical role in B cell proliferation.
  • IKKbeta is essential for controlling specific aspects of the humoral immune response, including antibody production.

More Related Videos

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α11:27

A Guide to Production, Crystallization, and Structure Determination of Human IKK1/α

Published on: November 2, 2018

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...